Pfizer dealt another blow as Torisel fails kidney cancer trial
Results are another setback in company’s bid to extend the indications for its mTOR inhibitor
Read More
Section: Research
Merck Serono resolves labour dispute over Swiss closures
Will offer additional benefits to affected employees
Read MoreAmgen-Takeda’s ganitumab fails in pancreatic cancer study
Interim analysis shows no improvement in overall survival
Read More
New cancer drugs safer for patients, says study
NHS and research charity sees huge benefits in targeted cancer therapies
Read MoreAstraZeneca and BGT shelve experimental sepsis drug
Decision follows CytoFab’s poor mid-stage clinical trial results
Read More